Counter-regulatory effects of phosphatidic acid on protein kinase C activity in the presence of calcium and diolein.

Rapid desensitization and resensitization of bombesin-stimulated phospholipase D activity in Swiss 3T3 cells. Biochem J (1994) 0.81

Purification and characterization of N-ethylmaleimide-insensitive phosphatidic acid phosphohydrolase (PAP2) from rat liver. Biochem J (1995) 0.79

Evidence for allosteric linkage between exosites 1 and 2 of thrombin. J Biol Chem (1997) 1.02

Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II. J Biol Chem (1999) 0.93

Dimerization of the P-glycoprotein in membranes. Biochim Biophys Acta (1990) 0.91

Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase. J Biol Chem (2000) 0.91

Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. J Biol Chem (1999) 0.88

Conformational changes in thrombin when complexed by serpins. J Biol Chem (2001) 0.87

Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation. J Thromb Haemost (2012) 0.86

Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin. J Biol Chem (2001) 0.86

Lipid vesicles which can bind to protein kinase C and activate the enzyme in the presence of EGTA. Eur J Biochem (1992) 0.82

The relationship between the bilayer to hexagonal phase transition temperature in membranes and protein kinase C activity. Biosci Rep (1988) 0.82

Vasoflux, a new anticoagulant with a novel mechanism of action. Circulation (1999) 0.79

Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure. Eur J Biochem (1987) 0.79

Studies on the mechanism of action of a bilayer stabilizing inhibitor of protein kinase C: cholesterylphosphoryldimethylethanolamine. Biosci Rep (1989) 0.79

Localization of the thrombin-binding domain on prothrombin fragment 2. J Biol Chem (1998) 0.78

Molecular basis for the resistance of fibrin-bound thrombin to inactivation by heparin/serpin complexes. Adv Exp Med Biol (1997) 0.78

Chemical and biological reactivity of insoluble nickel compounds and the bioinorganic chemistry of nickel. IARC Sci Publ (1984) 0.77

Mechanism of action of diabetogenic zinc-chelating agents. Model system studies. Mol Pharmacol (1985) 0.76

Calcitonin inhibits the rise of intracellular calcium induced by thyrotropin-releasing hormone in GH3 cells. Cell Calcium (1989) 0.76

Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule. J Med Chem (1988) 0.76

Action of insulin in rat adipocytes and membrane properties. Biochemistry (1991) 0.75

Cellular binding and/or uptake of nickel(II) ions. IARC Sci Publ (1984) 0.75